John Nuss
2021
In 2021, John Nuss earned a total compensation of $5M as Chief Scientific Officer at Ventyx Biosciences, a 3,584% increase compared to previous year.
Compensation breakdown
| Bonus | $204,000 |
|---|---|
| Option Awards | $2,398,783 |
| Salary | $370,928 |
| Stock Awards | $2,023,175 |
| Total | $4,996,886 |
Nuss received $2.4M in option awards, accounting for 48% of the total pay in 2021.
Nuss also received $204K in bonus, $370.9K in salary and $2M in stock awards.
Rankings
In 2021, John Nuss' compensation ranked 2,620th out of 12,415 executives tracked by ExecPay. In other words, Nuss earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,620 out of 12,415 | 79th |
Division Manufacturing | 1,035 out of 5,501 | 81st |
Major group Chemicals And Allied Products | 402 out of 2,371 | 83rd |
Industry group Drugs | 352 out of 2,092 | 83rd |
Industry Pharmaceutical Preparations | 230 out of 1,542 | 85th |
Source: SEC filing on April 27, 2022.
Nuss' colleagues
We found two more compensation records of executives who worked with John Nuss at Ventyx Biosciences in 2021.